Apimeds Pharmaceuticals sinks 23% to $5.42 after two-day surge, data show

Apimeds Pharmaceuticals US shares fell 23.05% to $5.42, landing among the day’s top losers, according to Financial Modeling Prep. The drop followed sharp gains earlier this week highlighted by kalkine.ca.